Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$43.48 USD
+4.24 (10.81%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $43.44 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
QTTB 43.48 +4.24(10.81%)
Will QTTB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for QTTB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QTTB
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 91.69%: Read This Before Placing a Bet
QTTB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for QTTB
Q32 Bio to Participate in Upcoming September Investor Conferences
Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097
Analysts Have Conflicting Sentiments on These Healthcare Companies: Edwards Lifesciences (EW), Immunovant (IMVT) and Q32 Bio (QTTB)
Analysts Are Bullish on These Healthcare Stocks: Q32 Bio (QTTB), Wave Life Sciences (WVE)
QTTB Stock Earnings: Q32 Bio Misses EPS for Q2 2024